Edmond DE Rothschild Holding S.A. Acquires 65,000 Shares of DENTSPLY SIRONA Inc. $XRAY

Edmond DE Rothschild Holding S.A. increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) by 1.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,568,300 shares of the medical instruments supplier’s stock after purchasing an additional 65,000 shares during the quarter. Edmond DE Rothschild Holding S.A. owned 2.31% of DENTSPLY SIRONA worth $40,475,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of XRAY. Nykredit A S acquired a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $38,000. Allworth Financial LP acquired a new stake in DENTSPLY SIRONA in the 2nd quarter valued at $51,000. IFP Advisors Inc increased its holdings in DENTSPLY SIRONA by 244.4% in the 3rd quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock worth $49,000 after acquiring an additional 3,950 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth $69,000. Finally, HighTower Advisors LLC acquired a new position in DENTSPLY SIRONA during the third quarter worth $90,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $8.49 on Friday. DENTSPLY SIRONA Inc. has a one year low of $8.14 and a one year high of $14.76. The firm’s 50 day moving average price is $9.25 and its 200-day moving average price is $11.12. The firm has a market cap of $1.68 billion, a P/E ratio of -13.69, a P/E/G ratio of 1.25 and a beta of 0.87. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.04 and a current ratio of 1.63.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.02). The firm had revenue of $836.00 million during the quarter, compared to analyst estimates of $861.68 million. DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The company’s quarterly revenue was down 7.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.37 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. As a group, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.21 EPS for the current year.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent analyst reports. BMO Capital Markets decreased their price objective on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a report on Thursday, September 17th. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Leerink Partners reduced their price target on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a research report on Wednesday, October 14th. Zacks Research lowered DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 9th. Finally, UBS Group decreased their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday. Three equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Reduce” and an average price target of $12.08.

Check Out Our Latest Analysis on XRAY

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.

Featured Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.